Product NDC: | 0039-0019 |
Proprietary Name: | Claforan |
Non Proprietary Name: | cefotaxime sodium |
Active Ingredient(s): | 2 g/1 & nbsp; cefotaxime sodium |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0039-0019 |
Labeler Name: | Sanofi-Aventis U.S. LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050547 |
Marketing Category: | NDA |
Start Marketing Date: | 20090622 |
Package NDC: | 0039-0019-11 |
Package Description: | 10 BOTTLE in 1 PACKAGE (0039-0019-11) > 1 INJECTION in 1 BOTTLE |
NDC Code | 0039-0019-11 |
Proprietary Name | Claforan |
Package Description | 10 BOTTLE in 1 PACKAGE (0039-0019-11) > 1 INJECTION in 1 BOTTLE |
Product NDC | 0039-0019 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | cefotaxime sodium |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20090622 |
Marketing Category Name | NDA |
Labeler Name | Sanofi-Aventis U.S. LLC |
Substance Name | CEFOTAXIME SODIUM |
Strength Number | 2 |
Strength Unit | g/1 |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |